Selank in Cato — Anxiolytic Peptide Research Guide
Selank peptide guide for Cato. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
For anyone in Cato looking to source Selank, the key fact to understand is that this compound is distributed via specialist online vendors. This matters because Selank quality differs enormously across the market — from pharmaceutical-grade 99%+ purity to material with significant impurity issues — and the vendor determines everything about the product. A legitimate Selank supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all batch-matched to your order. This guide gives Cato researchers the methodology to assess vendor quality rigorously and source verified-quality Selank with confidence.
How Selank Works — Mechanisms & Research
Selank belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in Cato studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
How to Source Selank — Vendor Guide
Quality Selank sourcing begins with a straightforward question: does this vendor share complete COA data without being asked? Those who make this data freely available are operating transparently. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from gram-negative bacterial contamination can trigger dangerous inflammatory cascades even at minute levels. Red flags in Selank vendor evaluation: prices significantly below market average, vague sourcing information, no community presence, and COAs that omit endotoxin testing. For Cato researchers making a first Selank purchase: verify the vendor against this framework, begin with a small order, and check that batch numbers on your vial match the COA before use.
Order Selank — ships to Cato
COA-verified · International tracking · Research grade
As a research compound, Selank has not completed the clinical trial process required for pharmaceutical approval — its safety profile is defined by animal study data and limited human studies. Reconstitute Selank with bacteriostatic water at the concentration suited to your research design; a standard 5mg in 2mL gives a 2.5mg/mL solution — or 25mcg per insulin syringe unit. Bacterial endotoxin contamination is the most serious safety risk unique to this class of compound — verify endotoxin testing is included in the batch-specific COA before any injectable research application. Researchers using Selank alongside other research compounds should check the research literature for any reported interactions before proceeding with any multi-compound protocol.
Frequently Asked Questions
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
